Notícias e Atividades da Arrakis Therapeutics

Veja o organograma con seus 18 executivos principais

Biografias mais buscadas da Arrakis Therapeutics

• Mark Delong, Chief Executive Officer
• Michael Gilman, Chairman of the Board
• Raj Parekh, Director

Recentes movimentos de executivos em Arrakis Therapeutics

• Michael Gilman antes Chief Executive Officer and Director, agora é Chairman of the Board  (Notícia publicada em 26 de junho de 2026).
• Mark Delong, ingressou na Companhia como Chief Executive Officer  (Notícia publicada em 26 de junho de 2026).
• Katrine Bosley, Chairman of its Board, deixou a Companhia  (Notícia publicada em 26 de junho de 2026).

Criar um alerta
para seguir os movimentos de executivos da Arrakis Therapeutics.

Arrakis Therapeutics possui 2.430 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Tempus has announced the acquisition of Personalis  (publicado em 20 de julho de 2026).
• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Robert Gould - Board Member da Fulcrum Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Arrakis Therapeutics

• Arrakis Therapeutics Announces CEO Transition with Mark DeLong Appointed as New CEO - Arrakis Therapeutics
• Arrakis Therapeutics Presents Data Highlighting Progress of Oral RNA targeted Small Molecule to Treat Myotonic Dystrophy Type 1 (DM1) - Arrakis Therapeutics
• Arrakis Therapeutics Announces Oral Presentation Describing RNA-targeted Small Molecule to Treat Myotonic Dystrophy at MDA Conference 2025 - Arrakis Therapeutics
• Arrakis Therapeutics Announces Presentations at Upcoming Scientific Meetings - Arrakis Therapeutics
• Arrakis Therapeutics Announces Presentations at Upcoming Spring Scientific Meetings - Arrakis Therapeutics
• Arrakis Therapeutics Announces Presentation of AI and Machine Learning Approaches to RNA-targeted Drug Discovery - Arrakis Therapeutics
• Jennifer Petter, Arrakis Chief Scientific Officer, is Contributing Author in Feature on Women Scientists in Journal of Medicinal Chemistry - Arrakis Therapeutics
• Arrakis Therapeutics Announces Presentations at Upcoming Fall Scientific Meetings - Arrakis Therapeutics
• Arrakis Therapeutics to Present at Jefferies Healthcare Conference - Arrakis Therapeutics
• Arrakis Therapeutics to Participate in Upcoming May Investor Conferences - Arrakis Therapeutics
• View more press releases Close

Redes sociais sobre Arrakis Therapeutics

• Arrakis Therapeutics na Wikipedia, Google News e Yahoo Finance
• Arrakis Therapeutics na LinkedIn, X (Twitter) e YouTube